Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-098445
Filing Date
2024-11-14
Accepted
2024-11-14 16:15:29
Documents
70
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0219774-10q_inmed.htm   iXBRL 10-Q 588516
2 CERTIFICATION ea021977401ex31-1_inmed.htm EX-31.1 11625
3 CERTIFICATION ea021977401ex31-2_inmed.htm EX-31.2 11617
4 CERTIFICATION ea021977401ex32-1_inmed.htm EX-32.1 3980
5 CERTIFICATION ea021977401ex32-2_inmed.htm EX-32.2 4029
11 GRAPHIC image_001.jpg GRAPHIC 4152
12 GRAPHIC image_002.jpg GRAPHIC 4152
  Complete submission text file 0001213900-24-098445.txt   4197855

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inm-20240930.xsd EX-101.SCH 34548
7 XBRL CALCULATION FILE inm-20240930_cal.xml EX-101.CAL 40061
8 XBRL DEFINITION FILE inm-20240930_def.xml EX-101.DEF 191889
9 XBRL LABEL FILE inm-20240930_lab.xml EX-101.LAB 353946
10 XBRL PRESENTATION FILE inm-20240930_pre.xml EX-101.PRE 202520
72 EXTRACTED XBRL INSTANCE DOCUMENT ea0219774-10q_inmed_htm.xml XML 381649
Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39685 | Film No.: 241462508
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)